{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:26:33Z","timestamp":1789118793789,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Dublin, Trinity College"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with increased risk of stroke and mortality. Effective management requires both patient engagement and clear understanding of treatment goals yet evidence suggests persistent gaps in knowledge and involvement in care. Pharmacists are increasingly involved in AF clinics, yet little is known about how patients perceive their role, particularly in the context of potential pharmacist prescribing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To explore patients\u2019 perspectives on the management of AF and the role of pharmacists in an Irish outpatient AF clinic, including attitudes toward potential pharmacist prescribing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A qualitative study was conducted using 15 one-to-one semi-structured interviews with adults aged\u2009\u2265\u200965 years attending a specialist AF clinic at Tallaght University Hospital, Dublin, Ireland. Interviews took place between March and May 2025. Participants were purposively sampled to capture a range of clinical and demographic characteristics. Interviews were audio-recorded, transcribed verbatim, and analysed using Braun and Clarke\u2019s six-step reflexive thematic analysis. An inductive approach was adopted. Coding and theme development were conducted iteratively, with a subset of transcripts independently reviewed by supervisors to enhance analytical rigour and consistency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five overarching themes were identified relating to understanding of AF, pharmacotherapy, satisfaction with care, perceptions of the pharmacist\u2019s role, and views on pharmacist prescribing. Participants demonstrated variable understanding of AF, with limited awareness of stroke risk despite consistent recognition of anticoagulant therapy. Knowledge of anticoagulant safety, particularly bleeding risk, was strong and well retained, whereas understanding of rate-control medicines was limited. Satisfaction with care was high; however, most participants adopted a passive role in decision-making, expressing trust in healthcare professionals. Pharmacists were frequently misidentified as doctors or nurses, reflecting limited role visibility. Once recognised, pharmacist input, particularly in anticoagulant counselling and medication advice, was highly valued. Views on pharmacist prescribing were mixed: while participants acknowledged pharmacists\u2019 expertise in medicines, many preferred doctors to retain prescribing responsibility due to established trust.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While patients spoke positively about pharmacists\u2019 input, many struggled to identify the pharmacist within the clinic and were unclear about the scope of their role. Gaps in understanding of stroke risk and broader treatment goals highlight the need for structured patient education. As Ireland considers expanding pharmacist prescribing beyond the current common conditions scheme in community pharmacy, strengthening patient education and fostering trust will be essential to optimise pharmacist-led AF services.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02155-7","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:52:28Z","timestamp":1777452748000},"page":"1840-1849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient perspectives on atrial fibrillation management and pharmacist roles in outpatient clinics: a qualitative study"],"prefix":"10.1007","volume":"48","author":[{"given":"Margaret","family":"Dennehy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Seoighe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathal","family":"Cadogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Murtagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"McAuliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"2155_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae176","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2024. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176.","journal-title":"Eur Heart J"},{"key":"2155_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59298","volume":"16","author":"SN Dasari","year":"2024","unstructured":"Dasari SN, Gadde ST, Myneni P, et al. Effectiveness of anticoagulants in reducing stroke risk among patients with atrial fibrillation. Cureus. 2024;16:e59298. https:\/\/doi.org\/10.7759\/cureus.59298.","journal-title":"Cureus"},{"key":"2155_CR3","doi-asserted-by":"publisher","first-page":"A4118668-A","DOI":"10.1161\/circ.150.suppl_1.4118668","volume":"150","author":"M Gill","year":"2024","unstructured":"Gill M, Jones K, Ghosal R, et al. Abstract 4118668: understanding medication adherence to oral anticoagulants in atrial fibrillation management: patient and provider perspectives in a mixed methods study. Circulation. 2024;150:A4118668-A. https:\/\/doi.org\/10.1161\/circ.150.suppl_1.4118668.","journal-title":"Circulation"},{"key":"2155_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-023-02260-x","volume":"23","author":"HH Chiu","year":"2023","unstructured":"Chiu HH, Chang SL, Cheng HM, et al. Shared decision making for anticoagulation reduces anxiety and improves adherence in patients with atrial fibrillation. BMC Med Inform Decis Mak. 2023;23:163. https:\/\/doi.org\/10.1186\/s12911-023-02260-x.","journal-title":"BMC Med Inform Decis Mak"},{"key":"2155_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11845-020-02343-y","volume":"190","author":"V Khalil","year":"2021","unstructured":"Khalil V, Blackley S, Subramaniam A. Evaluation of a pharmacist-led shared decision-making in atrial fibrillation and patients\u2019 satisfaction\u2014a before and after pilot study. Ir J Med Sci. 2021;190:819\u201324. https:\/\/doi.org\/10.1007\/s11845-020-02343-y.","journal-title":"Ir J Med Sci"},{"key":"2155_CR6","first-page":"284","volume":"240","author":"AH Krist","year":"2017","unstructured":"Krist AH, Tong ST, Aycock RA, et al. Engaging patients in decision-making and behavior change to promote prevention. Stud Health Technol Inform. 2017;240:284\u2013302.","journal-title":"Stud Health Technol Inform"},{"key":"2155_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/europace\/euv317","volume":"18","author":"W Amara","year":"2016","unstructured":"Amara W, Larsen TB, Sciaraffia E, et al. Patients\u2019 attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association. Europace. 2016;18:151\u20135. https:\/\/doi.org\/10.1093\/europace\/euv317.","journal-title":"Europace"},{"key":"2155_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/bmjebm-2022-112068","volume":"28","author":"VM Montori","year":"2023","unstructured":"Montori VM, Ruissen MM, Hargraves IG, et al. Shared decision-making as a method of care. BMJ Evid Based Med. 2023;28:213\u20137. https:\/\/doi.org\/10.1136\/bmjebm-2022-112068.","journal-title":"BMJ Evid Based Med"},{"key":"2155_CR9","first-page":"850","volume":"112","author":"C Mc Auliffe","year":"2019","unstructured":"Mc Auliffe C, Morrissey E, Vaughan M, et al. The role of the pharmacist in a multi-disciplinary atrial fibrillation clinic. Ir Med J. 2019;112:850.","journal-title":"Ir Med J"},{"key":"2155_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcae045","volume":"10","author":"B Kefale","year":"2024","unstructured":"Kefale B, Peterson GM, Mirkazemi C, et al. The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes. 2024;10:qcae045. https:\/\/doi.org\/10.1093\/ehjqcco\/qcae045.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2155_CR11","unstructured":". Tallaght University Hospital. Atrial fibrillation. Dublin: Tallaght University Hospital; 2025. Available from: https:\/\/www.tuh.ie\/Healthcare-Professionals\/How-to-Refer-a-Patient\/Atrial-Fibrillation.html. Accessed 13 April 2026"},{"key":"2155_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.21993","volume":"7","author":"RK Sandhu","year":"2024","unstructured":"Sandhu RK, Fradette M, Lin M, et al. Stroke risk reduction in atrial fibrillation through pharmacist prescribing: a randomized clinical trial. JAMA Netw Open. 2024;7:e2421993. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.21993.","journal-title":"JAMA Netw Open"},{"key":"2155_CR13","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpo.2023.0113","volume":"8","author":"R Sharma","year":"2024","unstructured":"Sharma R, Hasan SS, Gilkar IA, et al. Pharmacist-led interventions in optimising the use of oral anticoagulants in patients with atrial fibrillation in general practice in England: a retrospective observational study. BJGP Open. 2024;8:BJGPO.2023.0113. https:\/\/doi.org\/10.3399\/bjgpo.2023.0113.","journal-title":"BJGP Open"},{"key":"2155_CR14","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s11096-021-01302-6","volume":"43","author":"H Haque","year":"2021","unstructured":"Haque H, Alrowily A, Jalal Z, et al. Direct oral anticoagulant-related medication incidents and pharmacists\u2019 interventions in hospital in-patients: evaluation using Reason\u2019s accident causation theory. Int J Clin Pharm. 2021;43:1693\u2013704. https:\/\/doi.org\/10.1007\/s11096-021-01302-6.","journal-title":"Int J Clin Pharm"},{"key":"2155_CR15","unstructured":"Department of Health. Expert Taskforce to Support the Expansion of the Role of Pharmacy Final Report. Dublin: Department of Health; 2024. Available from: https:\/\/www.gov.ie\/en\/department-of-health\/publications\/expert-taskforce-to-support-the-expansion-of-the-role-of-pharmacy-final-report\/ Accessed 13 April 2026"},{"key":"2155_CR16","unstructured":"Pharmaceutical Society of Ireland. Common Conditions Service. Dublin: PSI; 2026. Available from: https:\/\/www.psi.ie\/information-and-resources\/common-conditions-service Accessed 13 April 2026"},{"key":"2155_CR17","unstructured":"HSE. Advanced Specialist Pharmacists: Application and Validation process. 2023"},{"key":"2155_CR18","doi-asserted-by":"publisher","first-page":"A150","DOI":"10.1136\/ejhpharm-2026-eahp.306","volume":"33","author":"E Mcmanus","year":"2026","unstructured":"Mcmanus E, Dalton K, Keating J, et al. 4CPS-207 A scoping review of advanced or specialist pharmacist roles in hospital outpatient settings. Eur J Hosp Pharm. 2026;33:A150\u20131. https:\/\/doi.org\/10.1136\/ejhpharm-2026-eahp.306.","journal-title":"Eur J Hosp Pharm"},{"key":"2155_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care"},{"key":"2155_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114523","volume":"292","author":"M Hennink","year":"2022","unstructured":"Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med. 2022;292:114523. https:\/\/doi.org\/10.1016\/j.socscimed.2021.114523.","journal-title":"Soc Sci Med"},{"key":"2155_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"key":"2155_CR22","doi-asserted-by":"publisher","DOI":"10.31083\/rcm39233","volume":"26","author":"V Vyas","year":"2025","unstructured":"Vyas V, Vyas V, Sharma A, et al. Anticoagulation for stroke prevention in patients with atrial fibrillation: a review of the literature and current guidelines. Rev Cardiovasc Med. 2025;26:39233. https:\/\/doi.org\/10.31083\/rcm39233.","journal-title":"Rev Cardiovasc Med"},{"key":"2155_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy8020054","volume":"8","author":"C Metaxas","year":"2020","unstructured":"Metaxas C, Albert V, Habegger S, et al. Patient knowledge about oral anticoagulation therapy assessed during an intermediate medication review in Swiss community pharmacies. Pharmacy Basel. 2020;8:54. https:\/\/doi.org\/10.3390\/pharmacy8020054.","journal-title":"Pharmacy Basel"},{"key":"2155_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-015-0504-1","volume":"16","author":"C Ferguson","year":"2016","unstructured":"Ferguson C, Inglis SC, Newton PJ, et al. Education and practice gaps on atrial fibrillation and anticoagulation: a survey of cardiovascular nurses. BMC Med Educ. 2016;16:9. https:\/\/doi.org\/10.1186\/s12909-015-0504-1.","journal-title":"BMC Med Educ"},{"key":"2155_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/europace\/euv448","volume":"18","author":"A Hern\u00e1ndez Madrid","year":"2016","unstructured":"Hern\u00e1ndez Madrid A, Potpara TS, Dagres N, et al. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association. Europace. 2016;18:463\u20137. https:\/\/doi.org\/10.1093\/europace\/euv448.","journal-title":"Europace"},{"key":"2155_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.hroo.2024.04.005","volume":"5","author":"R Dutta","year":"2024","unstructured":"Dutta R, Ryan JG, Hurley S, et al. A targeted educational intervention increases oral anticoagulation rates in high-risk atrial fibrillation patients. Heart Rhythm O2. 2024;5:294\u2013300. https:\/\/doi.org\/10.1016\/j.hroo.2024.04.005.","journal-title":"Heart Rhythm O2"},{"key":"2155_CR27","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2024.17","volume":"20","author":"M Bhandari","year":"2025","unstructured":"Bhandari M, Pradhan A, Vishwakarma P, et al. Direct oral anticoagulant use in older adults with atrial fibrillation: challenges and solutions. Eur Cardiol. 2025;20:e03. https:\/\/doi.org\/10.15420\/ecr.2024.17.","journal-title":"Eur Cardiol"},{"key":"2155_CR28","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/2396987321989865","volume":"6","author":"E Berge","year":"2021","unstructured":"Berge E, Whiteley W, Audebert H, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6:I\u2013lxii. https:\/\/doi.org\/10.1177\/2396987321989865.","journal-title":"Eur Stroke J"},{"key":"2155_CR29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.4070\/kcj.2019.0234","volume":"49","author":"N Lowres","year":"2019","unstructured":"Lowres N, Giskes K, Hespe C, et al. Reducing stroke risk in atrial fibrillation: adherence to guidelines has improved, but patient persistence with anticoagulant therapy remains suboptimal. Korean Circ J. 2019;49:883\u2013907. https:\/\/doi.org\/10.4070\/kcj.2019.0234.","journal-title":"Korean Circ J"},{"key":"2155_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/ehjqcco\/qcaa040","volume":"6","author":"F Ali-Ahmed","year":"2020","unstructured":"Ali-Ahmed F, Pieper K, North R, et al. Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions. Eur Heart J Qual Care Clin Outcomes. 2020;6:263\u201372. https:\/\/doi.org\/10.1093\/ehjqcco\/qcaa040.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2155_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/geriatrics5040085","volume":"5","author":"P Aggarwal","year":"2020","unstructured":"Aggarwal P, Woolford SJ, Patel HP. Multi-morbidity and polypharmacy in older people: challenges and opportunities for clinical practice. Geriatrics. 2020;5:85. https:\/\/doi.org\/10.3390\/geriatrics5040085.","journal-title":"Geriatrics"},{"key":"2155_CR32","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.mayocp.2018.08.030","volume":"94","author":"CL Zeballos-Palacios","year":"2019","unstructured":"Zeballos-Palacios CL, Hargraves IG, Noseworthy PA, et al. Developing a conversation aid to support shared decision making: reflections on designing anticoagulation choice. Mayo Clin Proc. 2019;94:686\u201396. https:\/\/doi.org\/10.1016\/j.mayocp.2018.08.030.","journal-title":"Mayo Clin Proc"},{"key":"2155_CR33","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jacep.2019.08.007","volume":"5","author":"C Gallagher","year":"2019","unstructured":"Gallagher C, Rowett D, Nyfort-Hansen K, et al. Patient-centered educational resources for atrial fibrillation. JACC Clin Electrophysiol. 2019;5:1101\u201314. https:\/\/doi.org\/10.1016\/j.jacep.2019.08.007.","journal-title":"JACC Clin Electrophysiol"},{"key":"2155_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"key":"2155_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/0272989x221121350","volume":"43","author":"KA Martinez","year":"2023","unstructured":"Martinez KA, Linfield DT, Shaker V, et al. Informed decision making for anticoagulation therapy for atrial fibrillation. Med Decis Making. 2023;43:263\u20139. https:\/\/doi.org\/10.1177\/0272989x221121350.","journal-title":"Med Decis Making"},{"key":"2155_CR36","first-page":"268","volume":"45","author":"R Morillo-Verdugo","year":"2021","unstructured":"Morillo-Verdugo R, \u00c1lvarez-D\u00edaz A, Gorgas-Torner MQ, et al. Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project. Farm Hosp. 2021;45:268\u201376.","journal-title":"Farm Hosp"},{"key":"2155_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1476464","volume":"15","author":"C Amrouch","year":"2024","unstructured":"Amrouch C, Vetrano DL, Damiano C, et al. Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity: a Swedish national register-based cohort study. Front Pharmacol. 2024;15:1476464. https:\/\/doi.org\/10.3389\/fphar.2024.1476464.","journal-title":"Front Pharmacol"},{"key":"2155_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/17151635211019963","volume":"154","author":"L Adam","year":"2021","unstructured":"Adam L. Potential benefits of pharmacist intervention in the detection and therapy of atrial fibrillation. Can Pharm J. 2021;154:240\u20131. https:\/\/doi.org\/10.1177\/17151635211019963.","journal-title":"Can Pharm J"},{"key":"2155_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2022.100165","volume":"17","author":"BJ Domaleczny","year":"2022","unstructured":"Domaleczny BJ, Lewis SJ, Richardson JL, et al. Impact of pharmacist intervention to deprescribe inappropriate aspirin therapy in an outpatient anticoagulation clinic at a community hospital. Am Heart J Plus Cardiol Res Pract. 2022;17:100165. https:\/\/doi.org\/10.1016\/j.ahjo.2022.100165.","journal-title":"Am Heart J Plus Cardiol Res Pract"},{"key":"2155_CR40","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1136\/ejhpharm-2021-002726","volume":"28","author":"L Ferro-L\u00f3pez","year":"2021","unstructured":"Ferro-L\u00f3pez L, Barnett N, Minshull J. Improving shared decision-making in pharmacist-led haematology clinics: a \u201cPlan Do Study Act\u201d approach. Eur J Hosp Pharm. 2021;28:e180\u20134. https:\/\/doi.org\/10.1136\/ejhpharm-2021-002726.","journal-title":"Eur J Hosp Pharm"},{"key":"2155_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/iprp.S397844","volume":"13","author":"EL Veale","year":"2024","unstructured":"Veale EL. Pharmacy-led management of atrial fibrillation: improving treatment adherence and patient outcomes. Integr Pharm Res Pract. 2024;13:101\u201314. https:\/\/doi.org\/10.2147\/iprp.S397844.","journal-title":"Integr Pharm Res Pract"},{"key":"2155_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/eurjcn\/zvae092","volume":"23","author":"W Xu","year":"2024","unstructured":"Xu W, Wu T, Chen J, et al. Effects of intensive, targeted education by pharmacists on anticoagulant patients with atrial fibrillation: a multicentre randomized controlled trial from China. Eur J Cardiovasc Nurs. 2024;23:zvea092. https:\/\/doi.org\/10.1093\/eurjcn\/zvae092.","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2155_CR43","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/jcpt.13628","volume":"47","author":"B Shahrami","year":"2022","unstructured":"Shahrami B, Sefidani Forough A, Najmeddin F, et al. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic. J Clin Pharm Ther. 2022;47:964\u201372. https:\/\/doi.org\/10.1111\/jcpt.13628.","journal-title":"J Clin Pharm Ther"},{"key":"2155_CR44","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1007\/s11096-016-0357-7","volume":"38","author":"WB Chua","year":"2016","unstructured":"Chua WB, Cheen HH, Kong MC, et al. Modelling the cost-effectiveness of pharmacist-managed anticoagulation service for older adults with atrial fibrillation in Singapore. Int J Clin Pharm. 2016;38:1230\u201340. https:\/\/doi.org\/10.1007\/s11096-016-0357-7.","journal-title":"Int J Clin Pharm"},{"key":"2155_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82285-y","volume":"14","author":"N Tantipinichwong","year":"2024","unstructured":"Tantipinichwong N, Keller MS. Operation polypharmacy: A pharmacist-led ambulatory care clinic design and evaluation for older patients. Sci Rep. 2024;14:31719. https:\/\/doi.org\/10.1038\/s41598-024-82285-y.","journal-title":"Sci Rep"},{"key":"2155_CR46","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.amjmed.2022.07.014","volume":"135","author":"LA Ritchie","year":"2022","unstructured":"Ritchie LA, Penson PE, Akpan A, et al. Integrated care for atrial fibrillation management: the role of the pharmacist. Am J Med. 2022;135:1410\u201326. https:\/\/doi.org\/10.1016\/j.amjmed.2022.07.014.","journal-title":"Am J Med"},{"key":"2155_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/17151635251365148","author":"FS Tonin","year":"2025","unstructured":"Tonin FS, Tsuyuki RT, Fernandez-Llimos F, et al. The role of pharmacists in the management of patients with atrial fibrillation: a systematic review and meta-analysis. Can Pharm J. 2025. https:\/\/doi.org\/10.1177\/17151635251365148.","journal-title":"Can Pharm J"},{"key":"2155_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2024.100522","volume":"16","author":"E Deasy","year":"2024","unstructured":"Deasy E, Seoighe A, Ryan C, et al. Pharmacy stakeholders\u2019 views and experiences of the credentialing of advanced or specialist pharmacist practice: a mixed methods systematic review. Explor Res Clin Soc Pharm. 2024;16:100522. https:\/\/doi.org\/10.1016\/j.rcsop.2024.100522.","journal-title":"Explor Res Clin Soc Pharm"},{"key":"2155_CR49","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/bcp.13624","volume":"84","author":"T Jebara","year":"2018","unstructured":"Jebara T, Cunningham S, MacLure K, et al. Stakeholders\u2019 views and experiences of pharmacist prescribing: a systematic review. Br J Clin Pharmacol. 2018;84:1883\u2013905. https:\/\/doi.org\/10.1111\/bcp.13624.","journal-title":"Br J Clin Pharmacol"},{"key":"2155_CR50","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.sapharm.2021.02.005","volume":"17","author":"AW Olson","year":"2021","unstructured":"Olson AW, Vaidyanathan R, Stratton TP, et al. Patient-centered care preferences & expectations in outpatient pharmacist practice: a three archetype heuristic. Res Social Adm Pharm. 2021;17:1820\u201330. https:\/\/doi.org\/10.1016\/j.sapharm.2021.02.005.","journal-title":"Res Social Adm Pharm"},{"key":"2155_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1715163517743269","volume":"151","author":"RK Sandhu","year":"2018","unstructured":"Sandhu RK, Guirguis LM, Bungard TJ, et al. Evaluating the potential for pharmacists to prescribe oral anticoagulants for atrial fibrillation. Can Pharm J. 2018;151:51\u201361. https:\/\/doi.org\/10.1177\/1715163517743269.","journal-title":"Can Pharm J"},{"key":"2155_CR52","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.sapharm.2024.01.006","volume":"20","author":"RL Walpola","year":"2024","unstructured":"Walpola RL, Issakhany D, Gisev N, et al. The accessibility of pharmacist prescribing and impacts on medicines access: a systematic review. Res Social Adm Pharm. 2024;20:475\u201386. https:\/\/doi.org\/10.1016\/j.sapharm.2024.01.006.","journal-title":"Res Social Adm Pharm"},{"key":"2155_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-023-01273-4","volume":"18","author":"SN Smith","year":"2023","unstructured":"Smith SN, Lanham M, Seagull FJ, et al. Implementing pharmacist-prescriber collaboration to improve evidence-based anticoagulant use: a randomized trial. Implement Sci. 2023;18:16. https:\/\/doi.org\/10.1186\/s13012-023-01273-4.","journal-title":"Implement Sci"},{"key":"2155_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/20523211.2024.2321592","volume":"17","author":"S Al-Arkee","year":"2024","unstructured":"Al-Arkee S, Mason J, Haque MS, et al. Pharmacist management of atrial fibrillation in UK primary care: a cross-sectional study. J Pharm Policy Pract. 2024;17:2321592. https:\/\/doi.org\/10.1080\/20523211.2024.2321592.","journal-title":"J Pharm Policy Pract"},{"key":"2155_CR55","unstructured":"NHS England. NHS long term workforce plan. London: NHS England; 2023. Available from: https:\/\/www.england.nhs.uk\/publication\/nhs-long-term-workforce-plan\/ Accessed 13 April 2026"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02155-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02155-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02155-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:58:48Z","timestamp":1789117128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-026-02155-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2155"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02155-7","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted by the Tallaght University Hospital\/St James\u2019s Hospital Joint Research Ethics Committee (Reference: 4056; approved 12 February 2025).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to participation in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}